Regulating membrane lipid levels at the synapse by small-molecule inhibitors of monoacylglycerol lipase: new developments in therapeutic and PET imaging applications

Natasha L. Grimsey, Juha R. Savinainen, Bala Attili, Muneer Ahamed

Research output: Contribution to journalReview articlepeer-review

8 Citations (Scopus)


Monoacylglycerol lipase (MAGL) is a major endocannabinoid hydrolyzing enzyme and can be regulated to control endogenous lipid levels in the brain. This review highlights the pharmacological roles and in vivo PET imaging of MAGL in brain.

Original languageEnglish
Pages (from-to)330-343
Number of pages14
JournalDrug Discovery Today
Issue number2
Publication statusPublished or Issued - Feb 2020
Externally publishedYes

ASJC Scopus subject areas

  • Pharmacology
  • Drug Discovery

Cite this